MARKER THERAPEUTICS, INC. (MRKR)
Clinical trial NCT06193252 updates: 1. completion date: 2027-12-01 → 2028-12-01 2. primary completion date: 2027-12-01 → 2028-12-01
Clinical trial NCT06193252 updates: 1. completion date: 2027-12-01 → 2028-12-01 2. primary completion date: 2027-12-01 → 2028-12-01
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical